Apotex Case Shows Inequitable Conduct Is Still A Potent Tool
A recent Federal Circuit ruling that an Apotex Inc. patent is unenforceable because of misconduct by the company's chairman makes clear that although a 2011 decision made inequitable conduct very difficult...To view the full article, register now.
Already a subscriber? Click here to view full article